Afluria Quadrivalent Global Market Report 2025

Global Afluria Quadrivalent Market Report 2025

Afluria Quadrivalent Global Market Report 2025 – By Clinical Indication (Seasonal Influenza Prophylaxis, High-Risk Population Immunization, Pediatric Influenza Prophylaxis, Healthcare Worker Immunization), By Route Of Administration (Injection, Nasal Spray), By Age Group (Adults, Geriatric, Pediatrics), By Distribution Channel (Hospital And Retail Pharmacies, Government Suppliers, Other Channels), By End-User (Hospitals, Public, Private, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Afluria Quadrivalent Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Afluria Quadrivalent Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Afluria Quadrivalent Global Market Report 2025

Proud Members Of

Afluria Quadrivalent Market Definition

Afluria quadrivalent is a vaccine used to prevent infection from four different strains of the influenza virus: two strains of influenza A (H1N1 and H3N2) and two strains of influenza B. It is designed to protect against the flu during the flu season, which typically occurs annually. Afluria quadrivalent is administered via Injection and is approved for use in individuals aged 6 months and older.

The main clinical indications of afluria quadrivalent are seasonal influenza prophylaxis, high-risk population immunization, pediatric influenza prophylaxis, healthcare worker immunization. Seasonal Influenza Prophylaxis refers to the preventive use of vaccines, like the Afluria Quadrivalent, to reduce the risk of contracting seasonal influenza caused by the circulating strains of the influenza virus. The routes of administration are injection and Nasal Spray. The various age groups include adults, geriatric, and pediatrics, and distribution channels include hospitals and retail pharmacies, government suppliers, and others. The different end users encompass hospitals, public, private, clinics, and others.

Afluria Quadrivalent Market Segmentation

The afluria quadrivalentmarket covered in this report is segmented –

1) By Clinical Indication: Seasonal Influenza Prophylaxis, High-Risk Population Immunization, Pediatric Influenza Prophylaxis, Healthcare Worker Immunization

2) By Route Of Administration: Injection, Nasal Spray

3) By Age Group: Adults, Geriatric, Pediatrics

4) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Channels

5) By End-User: Hospitals, Public, Private, Clinics, Other End-Users

Afluria Quadrivalent Market Size and growth rate 2025 to 2029: Graph

Afluria Quadrivalent Market Size 2025 And Growth Rate

The afluria quadrivalent market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising prevalence of chronic and infectious diseases, rising public awareness of the benefits of vaccination, growing geriatric population, increasing vaccination rates by government, and increasing consumer preference for vaccines.

Afluria Quadrivalent Market Growth Forecast

The afluria quadrivalent market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to promoting vaccination by government campaigns and healthcare providers, growing advancements in vaccine technology, increased investments by manufacturers to upgrade traditional vaccination production, increasing preference for quadrivalent vaccines among medical professionals, implementation of various programs and strategies to increase the uptake of vaccines. Major trends in the forecast period include developing innovative solutions, advanced technology providing better protection against virus mutations, innovative vaccine technologies, such as adjuvanted or quadrivalent vaccines, innovative vaccine technologies, such as adjuvanted or quadrivalent vaccines, and ongoing research and development efforts in vaccine technology.

Book your 30 minutes free consultation with our research experts

Afluria Quadrivalent Market Driver: Impact Of Rising Influenza Prevalence On The Growth Of The Afluria Quadrivalent Market

The increasing prevalence of influenza is expected to propel the growth of the afluria quadrivalent market going forward. Influenza is a contagious respiratory illness caused by influenza viruses that can lead to mild to severe illness, including fever, cough, and body aches. The increasing prevalence of influenza is driven by factors such as the annual mutation of the virus, seasonal environmental conditions, and low vaccination coverage in certain populations. Afluria Quadrivalent plays a crucial role in combating the increasing prevalence of influenza by providing protection against four circulating flu strains, thereby reducing the risk of infection and mitigating the impact of seasonal outbreaks. For instance, in November 2024, according to the UK Health Security Agency, a UK-based government agency, influenza positivity rates in week 46 showed an increase, with a weekly average positivity rate of 3.9%, up from 3.3% the previous week. The highest positivity rates were observed in individuals aged 5 to 14, where the weekly average reached 11.6%, a rise from 8.8% in the previous week (week 45). Therefore, the increasing prevalence of influenza will drive the growth of the afluria quadrivalent market.

Afluria Quadrivalent Market Driver: Impact Of Increasing Birth Rates On The Afluria Quadrivalent Market Growth

Increasing birth rates are expected to propel the growth of the afluria quadrivalent market going forward. The increase in birth rates can be attributed to various factors, including improved healthcare, government incentives, and changing societal attitudes. A higher number of births leads to a larger pediatric population that requires immunization. As birth rates rise, healthcare systems need to administer vaccines to more children to prevent influenza, leading to increased demand for vaccines like Afluria Quadrivalent. For instance, in October 2024, according to the Australian Bureau of Statistics, an Australia-based government agency, there were 24,737 Aboriginal and Torres Strait Islander births registered in 2023, an increase of 349 babies from 2022. Thus, increasing birth rates are driving the growth of the afluria quadrivalent market.

Global Afluria Quadrivalent Market Major Players

Major companies operating in the afluria quadrivalent market include Seqirus Inc.

Afluria Quadrivalent Market Merger And Acquisition: Seqirus Partners With BARDA And University Of Liverpool To Enhance Flu Prevention Efforts

In July 2022, Seqirus, a UK-based influenza vaccine producer, partnered with the Biomedical Advanced Research and Development Authority (BARDA) and the University of Liverpool Pandemic Institute. These collaborations aimed to enhance vaccine distribution and improve public health outcomes. BARDA is a US government agency, that focuses on developing medical countermeasures for public health emergencies, while the University of Liverpool Pandemic Institute is a UK-based institute, that seeks to improve worldwide pandemic responses through research, preparedness, and policy development.

Regional Outlook For The Global Afluria Quadrivalent Market

North America was the largest region in the afluria quadrivalent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the afluria quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the afluria quadrivalent market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Afluria Quadrivalent Market?

The afluria quadrivalent consists of sales of pre-filled syringes, vaccine vials, adjuvanted and unadjuvanted versions, flu vaccine kits, related packaging, and storage equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Afluria Quadrivalent Industry?

The afluria quadrivalent market research report is one of a series of new reports from The Business Research Company that provides afluria quadrivalent market statistics, including afluria quadrivalent industry global market size, regional shares, competitors with a afluria quadrivalent market share, detailed afluria quadrivalent market segments, market trends, and opportunities, and any further data you may need to thrive in the afluria quadrivalent industry. This afluria quadrivalent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Afluria Quadrivalent Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Clinical Indication: Seasonal Influenza Prophylaxis, High-Risk Population Immunization, Pediatric Influenza Prophylaxis, Healthcare Worker Immunization 2) By Route Of Administration: Injection, Nasal Spray 3) By Age Group: Adults, Geriatric, Pediatrics 4) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Channels 5) By End-User: Hospitals, Public, Private, Clinics, Other End-Users
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Seqirus Inc.
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Afluria Quadrivalent Market Characteristics

3. Afluria Quadrivalent Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Afluria Quadrivalent Market Trends And Strategies

5. Afluria Quadrivalent Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Afluria Quadrivalent Growth Analysis And Strategic Analysis Framework

6.1. Global Afluria Quadrivalent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Afluria Quadrivalent Market Growth Rate Analysis

6.4. Global Afluria Quadrivalent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Afluria Quadrivalent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Afluria Quadrivalent Total Addressable Market (TAM)

7. Global Afluria Quadrivalent Market Pricing Analysis & Forecasts

8. Afluria Quadrivalent Market Segmentation

8.1. Global Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Seasonal Influenza Prophylaxis

High-Risk Population Immunization

Pediatric Influenza Prophylaxis

Healthcare Worker Immunization

8.2. Global Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injection

Nasal Spray

8.3. Global Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adults

Geriatric

Pediatrics

8.4. Global Afluria Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital And Retail Pharmacies

Government Suppliers

Other Channels

8.5. Global Afluria Quadrivalent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Public

Private

Clinics

Other End-Users

9. Global Afluria Quadrivalent Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Afluria Quadrivalent Market Regional And Country Analysis

10.1. Global Afluria Quadrivalent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Afluria Quadrivalent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Afluria Quadrivalent Market

11.1. Asia-Pacific Afluria Quadrivalent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Afluria Quadrivalent Market

12.1. China Afluria Quadrivalent Market Overview

12.2. China Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Afluria Quadrivalent Market

13.1. India Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Afluria Quadrivalent Market

14.1. Japan Afluria Quadrivalent Market Overview

14.2. Japan Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Afluria Quadrivalent Market

15.1. Australia Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Afluria Quadrivalent Market

16.1. South Korea Afluria Quadrivalent Market Overview

16.2. South Korea Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Afluria Quadrivalent Market

17.1. Western Europe Afluria Quadrivalent Market Overview

17.2. Western Europe Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Afluria Quadrivalent Market

18.1. UK Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Afluria Quadrivalent Market

19.1. Germany Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Afluria Quadrivalent Market

20.1. France Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Afluria Quadrivalent Market

21.1. Eastern Europe Afluria Quadrivalent Market Overview

21.2. Eastern Europe Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Afluria Quadrivalent Market

22.1. North America Afluria Quadrivalent Market Overview

22.2. North America Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Afluria Quadrivalent Market

23.1. USA Afluria Quadrivalent Market Overview

23.2. USA Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Afluria Quadrivalent Market

24.1. Canada Afluria Quadrivalent Market Overview

24.2. Canada Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Afluria Quadrivalent Market

25.1. South America Afluria Quadrivalent Market Overview

25.2. South America Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Afluria Quadrivalent Market

26.1. Middle East Afluria Quadrivalent Market Overview

26.2. Middle East Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Afluria Quadrivalent Market

27.1. Africa Afluria Quadrivalent Market Overview

27.2. Africa Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Afluria Quadrivalent Market Competitive Landscape And Company Profiles

28.1. Afluria Quadrivalent Market Competitive Landscape

28.2. Afluria Quadrivalent Market Company Profiles

28.2.1. Seqirus Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Afluria Quadrivalent Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Afluria Quadrivalent Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Afluria Quadrivalent Market

32. Recent Developments In The Afluria Quadrivalent Market

33. Afluria Quadrivalent Market High Potential Countries, Segments and Strategies

33.1 Afluria Quadrivalent Market In 2029 - Countries Offering Most New Opportunities

33.2 Afluria Quadrivalent Market In 2029 - Segments Offering Most New Opportunities

33.3 Afluria Quadrivalent Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Afluria Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Afluria Quadrivalent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Afluria Quadrivalent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Afluria Quadrivalent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: South Korea, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: South Korea, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Western Europe, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Western Europe, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: UK, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: UK, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Germany, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Germany, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: France, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: France, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: North America, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: North America, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: USA, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: USA, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Canada, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Canada, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: South America, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: South America, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Middle East, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Middle East, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Africa, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Africa, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Seqirus Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Afluria Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Afluria Quadrivalent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Afluria Quadrivalent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Afluria Quadrivalent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: South Korea, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: South Korea, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Western Europe, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Western Europe, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: UK, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: UK, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Germany, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Germany, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: France, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: France, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: North America, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: North America, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: USA, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: USA, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Canada, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Canada, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: South America, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: South America, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Middle East, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Middle East, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Africa, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Africa, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Seqirus Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the oncology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the vaccines market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the car-t therapy market research report 2022 with industry size, share, segments and market growth

Pertussis Vaccine Global Market Report 2025 – By Product Type (DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine), By Vaccine Type (Whole-Cell Vaccine, Acellular Vaccine), By Application (Children, Adults, Infants), By End-User (Vaccination Centers, Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

H1N1 Vaccine Global Market Report 2025 – By Product Type( Inactivated Vaccine, Live Attenuated Vaccine ), By Route Of Administration( Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination ), By End Users( Hospitals, Clinics, Research and Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Typhoid Vi Polysaccharide Vaccine Global Market Report 2025 – By Type( Child, Adult ), By Route of Administration( Oral, Parenteral ), By Application( Government Institution, Private Sector, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Adult Vaccines Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Application (Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis), By End Users (Healthcare Firms, Hospitals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Therapeutic BCG Vaccines Global Market Report 2025 – By Type (Therapy BCG, Immune BCG), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Influenza Diagnostic Global Market Report 2025 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests), By Molecular diagnostic tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End User (Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Influenza Vaccines Global Market Report 2025 – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric, Adult), By Distribution Channel (Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Influenza Treatment Global Market Report 2025 – By Product Type (Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Other Products), By Route Of Administration (Oral, Other Routes Of Administration), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Afluria Quadrivalent market?

Afluria quadrivalent is a vaccine used to prevent infection from four different strains of the influenza virus: two strains of influenza A (H1N1 and H3N2) and two strains of influenza B. It is designed to protect against the flu during the flu season, which typically occurs annually. Afluria quadrivalent is administered via injection and is approved for use in individuals aged 6 months and older. For further insights on the Afluria Quadrivalent market, request a sample here

How will the Afluria Quadrivalent market drivers and restraints affect the market dynamics? What forces will shape the Afluria Quadrivalent industry going forward?

The Afluria Quadrivalent market major growth driver - Impact Of Rising Influenza Prevalence On The Growth Of The Afluria Quadrivalent Market. For further insights on the Afluria Quadrivalent market, request a sample here

What is the forecast market size or the forecast market value of the Afluria Quadrivalent market?

The Afluria Quadrivalent market size has grown strongly in recent years. The afluria quadrivalent market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising prevalence of chronic and infectious diseases, rising public awareness of the benefits of vaccination, growing geriatric population, increasing vaccination rates by government, and increasing consumer preference for vaccines. The afluria quadrivalent market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to promoting vaccination by government campaigns and healthcare providers, growing advancements in vaccine technology, increased investments by manufacturers to upgrade traditional vaccination production, increasing preference for quadrivalent vaccines among medical professionals, implementation of various programs and strategies to increase the uptake of vaccines. Major trends in the forecast period include developing innovative solutions, advanced technology providing better protection against virus mutations, innovative vaccine technologies, such as adjuvanted or quadrivalent vaccines, innovative vaccine technologies, such as adjuvanted or quadrivalent vaccines, and ongoing research and development efforts in vaccine technology. For further insights on the Afluria Quadrivalent market, request a sample here

How is the Afluria Quadrivalent market segmented?

The afluria quadrivalentmarket covered in this report is segmented –
1) By Clinical Indication: Seasonal Influenza Prophylaxis; High-Risk Population Immunization; Pediatric Influenza Prophylaxis; Healthcare Worker Immunization
2) By Route Of Administration: Injection; Nasal Spray
3) By Age Group: Adults; Geriatric; Pediatrics
4) By Distribution Channel: Hospital And Retail Pharmacies; Government Suppliers; Other Channels
5) By End-User: Hospitals; Public; Private; Clinics; Other End-Users For further insights on the Afluria Quadrivalent market, request a sample here

Which region has the largest share of the Afluria Quadrivalent market? What are the other regions covered in the report?

Who are the major players in the Afluria Quadrivalent market?

Major companies operating in the afluria quadrivalent market include Seqirus Inc. . For further insights on the Afluria Quadrivalent market, request a sample here.

What are the key trends in the Afluria Quadrivalent market?

Major trends in the Afluria Quadrivalent market include . For further insights on the Afluria Quadrivalent market, request a sample here.

What are the major opportunities in the Afluria Quadrivalent market? What are the strategies for the Afluria Quadrivalent market?

For detailed insights on the major opportunities and strategies in the Afluria Quadrivalent market, request a sample here.

How does the Afluria Quadrivalent market relate to the overall economy and other similar markets?

For detailed insights on Afluria Quadrivalent's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Afluria Quadrivalent industry?

For detailed insights on the mergers and acquisitions in the Afluria Quadrivalent industry, request a sample here.

What are the key dynamics influencing the Afluria Quadrivalent market growth? SWOT analysis of the Afluria Quadrivalent market.

For detailed insights on the key dynamics influencing the Afluria Quadrivalent market growth and SWOT analysis of the Afluria Quadrivalent industry, request a sample here.